Philadelphia, PA · Founded 2021 · Privately Held (backing)
Operator of a T-cell therapeutics company intended to offer a therapeutic pipeline targeting clinical needs in oncology and autoimmune disease. ViTToria Biotherapeutics is based in Philadelphia, PA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2024, the last priced event on record. It has raised $49.9 million across 1 recorded round; the latest was an $8.7 million early-stage round in Jul 2021.
PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2024
Total raised
$49.9M
Last round
Early Stage VC
Jul 2021
No prints on record
No secondary trades in ViTToria Biotherapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ViTToria Biotherapeutics with a free account
·The complete investor list: 15 names
·Watch ViTToria Biotherapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of ViTToria Biotherapeutics stock.
